Search results
Showing 121 to 135 of 140 results for radiofrequency ablation
Percutaneous radiofrequency ablation for primary or secondary lung cancers (IPG372)
Interventional procedures, IPG372 - Issued: December 2010 --> We have moved interventional procedures guidance 372 to become HealthTech guidance 244. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Percutaneous radiofrequency ablation for primary and secondary lung cancers (IPG185)
This guidance has been updated and replaced by NICE HealthTech guidance 244.
Radiofrequency ablation for the treatment of colorectal metastases in the liver (IPG92)
This guidance has been updated and replaced by NICE HealthTech guidance 208.
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules (IPG562)
We have moved interventional procedures guidance 562 to become HealthTech guidance 416. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids (IPG689)
We have moved interventional procedures guidance 689 to become HealthTech guidance 572. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery (IPG121)
We have moved interventional procedures guidance 121 to become HealthTech guidance 72. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Sorafenib for treating advanced hepatocellular carcinoma (TA474)
Evidence-based recommendations on sorafenib (Nexavar) for treating advanced hepatocellular carcinoma in adults.
Interventional procedures, IPG294 - Issued: March 2009 --> We have moved interventional procedures guidance 294 to become HealthTech guidance 186. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Interventional procedures, IPG295 - Issued: March 2009 --> We have moved interventional procedures guidance 295 to become HealthTech guidance 187. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
This guidance has been updated and replaced by NICE HealthTech guidance 731.
We have moved interventional procedures guidance 496 to become HealthTech guidance 345. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
LiMAx system for assessing the functional capacity of the liver (MIB168)
NICE has developed a medtech innovation briefing (MIB) on LiMAx system for assessing the functional capacity of the liver .
This guidance has been updated and replaced by NICE interventional procedures guidance 614.
This guideline covers care for pregnant women and pregnant people with a twin or triplet pregnancy in addition to routine care during pregnancy and labour. It aims to reduce the risk of complications and improve outcomes.
Radiofrequency cold ablation for respiratory papillomatosis (IPG434)
Interventional procedures, IPG434 - Issued: November 2012 --> We have moved interventional procedures guidance 434 to become HealthTech guidance 295. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.